AGHC Aeon Global Health Corp

Price (delayed)

$0.06

Market cap

$594,904

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.01

Enterprise value

$2.95M

Highlights
Aeon Global Health's EPS has shrunk by 120% QoQ but it has increased by 12% YoY
The company's gross profit fell by 29% YoY but it rose by 9% QoQ
Aeon Global Health's net income has shrunk by 163% QoQ
Aeon Global Health's quick ratio has decreased by 30% QoQ and by 10% YoY

Key stats

What are the main financial stats of AGHC
Market
Shares outstanding
9.92M
Market cap
$594,904
Enterprise value
$2.95M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.23
Earnings
Revenue
$12.93M
EBIT
-$2.48M
EBITDA
-$2.01M
Free cash flow
$30,238
Per share
EPS
-$1.01
Free cash flow per share
$0
Book value per share
-$0.6
Revenue per share
$1.58
TBVPS
$0.48
Balance sheet
Total assets
$3.91M
Total liabilities
$9.89M
Debt
$3.11M
Equity
-$5.98M
Working capital
-$5.3M
Liquidity
Debt to equity
-0.52
Current ratio
0.36
Quick ratio
0.28
Net debt/EBITDA
-1.17
Margins
EBITDA margin
-15.6%
Gross margin
61.3%
Net margin
-61.7%
Operating margin
-23.7%
Efficiency
Return on assets
-93.2%
Return on equity
N/A
Return on invested capital
-49.5%
Return on capital employed
N/A
Return on sales
-19.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AGHC stock price

How has the Aeon Global Health stock price performed over time
Intraday
-25%
1 week
-14.29%
1 month
-50.04%
1 year
0%
YTD
17.65%
QTD
-64.71%

Financial performance

How have Aeon Global Health's revenue and profit performed over time
Revenue
$12.93M
Gross profit
$7.92M
Operating income
-$3.06M
Net income
-$7.98M
Gross margin
61.3%
Net margin
-61.7%
The net margin has plunged by 169% from the previous quarter and by 26% YoY
Aeon Global Health's net income has shrunk by 163% QoQ
The operating margin has plunged by 58% from the previous quarter
Aeon Global Health's operating income has shrunk by 54% QoQ

Growth

What is Aeon Global Health's growth rate over time

Valuation

What is Aeon Global Health stock price valuation
P/E
N/A
P/B
N/A
P/S
0.04
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.23
Aeon Global Health's EPS has shrunk by 120% QoQ but it has increased by 12% YoY
AGHC's price to sales (P/S) is 80% lower than its last 4 quarters average of 0.2
AGHC's revenue is down by 21% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Aeon Global Health business performance
AGHC's ROA has plunged by 196% from the previous quarter and by 45% YoY
The return on invested capital has dropped by 146% since the previous quarter and by 65% year-on-year
Aeon Global Health's return on sales has shrunk by 102% QoQ and by 78% YoY

Dividends

What is AGHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGHC.

Financial health

How did Aeon Global Health financials performed over time
Aeon Global Health's total assets is 60% lower than its total liabilities
Aeon Global Health's total assets has shrunk by 64% YoY and by 63% QoQ
Aeon Global Health's quick ratio has decreased by 30% QoQ and by 10% YoY
The debt is 152% more than the equity
Aeon Global Health's debt to equity has shrunk by 120% QoQ and by 108% YoY
The debt has increased by 2.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.